These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 25023882)

  • 1. Positive and negative effects of glitazones in carcinogenesis: experimental models vs. clinical practice.
    Bojková B; Orendáš P; Kubatka P; Péč M; Kassayová M; Kisková T; Kajo K
    Pathol Res Pract; 2014 Aug; 210(8):465-72. PubMed ID: 25023882
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glitazones in type 2 diabetes: an update.
    Drug Ther Bull; 2008 Apr; 46(4):25-9. PubMed ID: 18403615
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Pioglitazone. Review of its metabolic and systemic effects].
    Rodríguez Bernardino A; Cebrián Blanco S; Durán García S
    Rev Clin Esp; 2005 Dec; 205(12):610-20. PubMed ID: 16527183
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pioglitazone has a dubious bladder cancer risk but an undoubted cardiovascular benefit.
    Ryder RE
    Diabet Med; 2015 Mar; 32(3):305-13. PubMed ID: 25472014
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Too positive comment on glitazones].
    Lindberg M
    Ugeskr Laeger; 2007 Feb; 169(8):733; author reply 733. PubMed ID: 17338040
    [No Abstract]   [Full Text] [Related]  

  • 6. [Glucose-independent impact of the glitazones on the cardiovascular outcome].
    Hanefeld M
    MMW Fortschr Med; 2005 Jan; 147(1-2):37-9. PubMed ID: 15704569
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [The effect of glitazones on the progression of type 2 diabetes and on cardiovascular endpoints].
    Schatz H
    Dtsch Med Wochenschr; 2005 Aug; 130(31-32):1825-30. PubMed ID: 16052448
    [No Abstract]   [Full Text] [Related]  

  • 8. The role of glitazones in management of type 2 diabetes. A dream or a nightmare?
    Lindberg M; Astrup A
    Obes Rev; 2007 Sep; 8(5):381-4. PubMed ID: 17716295
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pioglitazone and cancer: angel or demon?
    Kostapanos MS; Elisaf MS; Mikhailidis DP
    Curr Pharm Des; 2013; 19(27):4913-29. PubMed ID: 23278487
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Can glitazones provide protection of the kidneys?].
    Bonnet F
    Journ Annu Diabetol Hotel Dieu; 2007; ():77-84. PubMed ID: 18610759
    [No Abstract]   [Full Text] [Related]  

  • 11. Glitazones and the cardiovascular system.
    Devchand PR
    Curr Opin Endocrinol Diabetes Obes; 2008 Apr; 15(2):188-92. PubMed ID: 18316956
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Glitazones and atherosclerosis].
    Staels B
    Ann Endocrinol (Paris); 2005 Apr; 66(2 Pt 2):1S24-31. PubMed ID: 15959402
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Thiazolidinedione derivatives in type 2 diabetes mellitus.
    Tack CJ; Smits P
    Neth J Med; 2006 Jun; 64(6):166-74. PubMed ID: 16788214
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Pioglitazone].
    Aso Y
    Nihon Rinsho; 2012 May; 70 Suppl 3():620-6. PubMed ID: 22768588
    [No Abstract]   [Full Text] [Related]  

  • 15. Glitazones in chronic kidney disease: potential and concerns.
    Bolignano D; Zoccali C
    Nutr Metab Cardiovasc Dis; 2012 Mar; 22(3):167-75. PubMed ID: 22364889
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pleiotropic effects of thiazolidinediones.
    Rizos CV; Liberopoulos EN; Mikhailidis DP; Elisaf MS
    Expert Opin Pharmacother; 2008 May; 9(7):1087-108. PubMed ID: 18422468
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Glitazones in the treatment of diabetes mellitus: clinical outcomes in large scale clinical trials.
    Charbonnel B
    Fundam Clin Pharmacol; 2007 Nov; 21 Suppl 2():19-20. PubMed ID: 18001315
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Glitazone use associated with reduced risk of Parkinson's disease.
    Brakedal B; Flønes I; Reiter SF; Torkildsen Ø; Dölle C; Assmus J; Haugarvoll K; Tzoulis C
    Mov Disord; 2017 Nov; 32(11):1594-1599. PubMed ID: 28861893
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Glitazones critically evaluated].
    Schernthaner G
    Dtsch Med Wochenschr; 2007 Dec; 132(49):2619. PubMed ID: 18050024
    [No Abstract]   [Full Text] [Related]  

  • 20. Insulin sensitization therapy and the heart: focus on metformin and thiazolidinediones.
    Wong AK; Struthers AD; Choy AM; Lang CC
    Heart Fail Clin; 2012 Oct; 8(4):539-50. PubMed ID: 22999238
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.